Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 171   

Articles published

PFE 33.36 -0.33 (-0.98%)
price chart
Critical Alerts For Invensense, Pfizer Inc., The Hartford Financial Services ...
Today's PriceWatch Alerts cover the following stocks: Invensense (NYSE: INVN), Pfizer Inc. (NYSE: PFE), The Hartford Financial Services Group Inc. (NYSE: HIG), The Chubb Corporation (NYSE: CB), AutoZone Inc. (NYSE: AZO).
Pfizer Report Warns of Possible Zoloft and Birth Defect Link
A Pfizer Inc. report shows a scientist warned executives last year about a potential link between the anti-depressant drug Zoloft and birth defects and recommended changes to the medication's safety warning.
Pfizer Inc. Still In Trouble Over Anti-depressant Drug Zoloft And Birth Defects  Bidness ETC
Pfizer (PFE) Stock Falling on Study Possibly Linking Viagra to Melanoma
"We rate PFIZER INC (PFE) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
Here's How Pfizer Inc., GlaxoSmithKline plc Vaccines Deal Works For Both ...
Pfizer Inc. (NYSE:PFE) has decided to acquire two meningitis vaccines from GlaxoSmithKline plc (ADR) (NYSE:GSK) for about $130 million.
Pfizer to Acquire Two Meningitis Vaccines From GlaxoSmithKline  Wall Street Journal
Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From ...  MarketWatch
Spark Therapeutics to Present With Pfizer Inc. Preclinical Data on Their Lead ...
Spark also is establishing a pipeline of gene therapy candidates to treat hematologic disorders and neurodegenerative diseases, including through a global collaboration with Pfizer Inc. for the development and commercialization of its SPK-FIX program ...
Dow Jones (DJIA) Today: Pfizer (PFE) Lower
Holding back the Dow today is Pfizer (NYSE: PFE), which is lagging the broader Dow index with a 22-cent decline (-0.7%) bringing the stock to $33.37.
Pfizer Inc (NYSE:PFE) Receives a "Overweight" from Piper Jaffray
Investment firm Piper Jaffray has started coverage on Pfizer Inc (NYSE:PFE)'s stock, rating it “Overweight”. This was revealed to clients in a report on 17 June.
Pfizer, Inc. (NYSE:PFE) Price Target Update  OTC Outlook
Laurie Olson Sold $894155 Worth of Pfizer Inc. (NYSE:PFE) Shares
We discovered in a public document submitted to the Washington-based Security and Exchange Commission that Laurie Olson, who works for Pfizer Inc. (NYSE:PFE) 33.96 -0.06 -0.18% , and currently serves as Executive Vice President performed an insider ...
Company Shares of Pfizer, Inc. Rally 0.35%  News Watch International
Pfizer Inc (PFE) Files Form 4 Insider Selling : Laurie J Olson Sells 26000 ...  Insider Trading Report
Is M&A The Only Way For Pfizer Inc. (PFE)?
Pfizer Inc. (NYSE:PFE) has not been able to generate consistent year-over-year revenue growth in the last several quarters.
Shares of Pfizer, Inc. (NYSE:PFE) Sees Large Outflow of Money  Money Flow Index
Stock Watch: Pfizer, Inc. (NYSE:PFE)  Markets Daily
Stocks With Perfect Match- Pfizer Inc. (NYSE:PFE), Baxter International Inc ...
Pfizer Inc. (NYSE:PFE) released that the U.S. FDA accepted for review Pfizer's new drug application (NDA) for XELJANZ (tofacitinib citrate) 11 mg once daily modified declared tablets for the treatment of moderate to severe rheumatoid arthritis (RA) in ...
Active Stock's Buzzers: Pfizer, (NYSE:PFE), Oasis Petroleum, (NYSE:OAS ...  wsnewspublishers
Pfizer Announces FDA Acceptance for Review of New Drug Application for A ...  MarketWatch